KKR Completes Acquisition of PharMerica
07 Décembre 2017 - 4:46PM
Business Wire
PharMerica Corporation (NYSE:PMC) today announced the completion
of the acquisition of PharMerica by a newly formed company
controlled by KKR with an affiliate of Walgreens Boots Alliance,
Inc. (Nasdaq: WBA) as a minority investor.
As a result of the completion of the acquisition, PharMerica
shareholders will receive an amount in cash equal to $29.25 per
share of PharMerica common stock, without interest. In connection
with the completion of the acquisition, shares of PharMerica’s
common stock will cease trading on the NYSE prior to the opening of
the NYSE on December 8, 2017.
UBS Investment Bank and BofA Merrill Lynch are serving as
financial advisors to PharMerica and Davis Polk & Wardwell LLP
is serving as PharMerica’s legal advisor. Simpson Thacher &
Bartlett LLP and Weil, Gotshal & Manges LLP are serving as
legal advisors to KKR and Walgreens Boots Alliance, Inc.,
respectively.
About PharMerica
PharMerica Corporation is a leading provider of pharmacy
services. PharMerica serves the long-term care, hospital pharmacy
management services, specialty home infusion and oncology pharmacy
markets. PharMerica operates 96 institutional pharmacies, 20
specialty home infusion pharmacies and 5 specialty oncology
pharmacies in 45 states. PharMerica’s customers are institutional
healthcare providers, such as skilled nursing facilities, assisted
living facilities, hospitals, individuals receiving in-home care
and patients with cancer.
About KKR
KKR is a leading global investment firm that manages multiple
alternative asset classes, including private equity, energy,
infrastructure, real estate, credit and, through its strategic
manager partnerships, hedge funds. KKR aims to generate attractive
investment returns by following a patient and disciplined
investment approach, employing world-class people, and driving
growth and value creation with KKR portfolio companies. KKR invests
its own capital alongside its partners' capital and provides
financing solutions and investment opportunities through its
capital markets business. References to KKR’s investments may
include the activities of its sponsored funds. For additional
information about KKR & Co. L.P. (NYSE: KKR), please visit
KKR's website at www.kkr.com and on Twitter @KKR_Co.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc. (Nasdaq: WBA) is the first global
pharmacy-led, health and wellbeing enterprise. The company’s
heritage of trusted health care services through community pharmacy
care and pharmaceutical wholesaling dates back more than 100
years.
Walgreens Boots Alliance is the largest retail pharmacy, health
and daily living destination across the U.S. and Europe. Walgreens
Boots Alliance and the companies in which it has equity method
investments together have a presence in more than 25* countries and
employ more than 385,000* people. The company is a global leader in
pharmacy-led, health and wellbeing retail and, together with the
companies in which it has equity method investments, has more than
13,200* stores in 11* countries as well as one of the largest
global pharmaceutical wholesale and distribution networks, with
more than 390* distribution centers delivering to more than
230,000** pharmacies, doctors, health centers and hospitals each
year in more than 20* countries. In addition, Walgreens Boots
Alliance is one of the world’s largest purchasers of prescription
drugs and many other health and wellbeing products.
The company’s portfolio of retail and business brands includes
Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as
increasingly global health and beauty product brands, such as No7,
Soap & Glory, Liz Earle, Sleek MakeUP and Botanics.
The company ranks No. 1 in the Food and Drug Stores industry of
Fortune magazine’s 2017 list of the World’s Most Admired
Companies.
More company information is available at
www.walgreensbootsalliance.com.
* As of 31 August 2017, using publicly available information for
AmerisourceBergen.** For 12 months ending 31 August 2017, using
publicly available information for AmerisourceBergen.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171207005802/en/
PharMerica CorporationRobert E. Dries,
502-627-7475Executive Vice President andChief Financial
OfficerorKKRKristi Huller / Cara Kleiman,
212-750-8300media@kkr.comorWalgreens Boots AllianceMedia
RelationsMichael Polzin, 847-315-2935Jim Cohn,
847-315-2950orInvestor RelationsGerald Gradwell / Ashish Kohli,
847-315-2922
Pharmerica Corp. (delisted) (NYSE:PMC)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Pharmerica Corp. (delisted) (NYSE:PMC)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024